RxDoctor Payments DataLook up a doctor →

Thomas Marbury

Nephrology · Orlando, FLNPI 1689734311

Payments from drug & device makers

$41,141,476in general payments, 2019–2025

Across 2,690 payments — averaging $15,294 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$4.1M
  • Incyte Corporation$2.8M
  • Amgen$2.6M
  • E.r. Squibb & Sons, L.L.C.$2.6M
  • Takeda Pharmaceuticals U.S.A., Inc.$2M
  • Bristol Myers Squibb$1.9M
  • plus $25.1M from 54 others
$53,631in research payments, 2019–2025

Across 9 payments — averaging $5959.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rockwell Medical, Inc.$49K
  • Eli Lilly$4K
  • Astellas Pharma Global Development$698

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly41$4,133,524
Incyte Corporation208$2,795,999
Amgen(2 entities)20$2,626,823
E.r. Squibb & Sons, L.L.C.19$2,597,785
Takeda Pharmaceuticals U.S.A., Inc.112$1,958,141
Bristol Myers Squibb29$1,887,181
Merck93$1,880,185
Pfizer161$1,878,610
Astrazeneca UK Limited11$1,765,461
Genentech, Inc.143$1,684,539
Bayer76$1,615,227
AbbVie(2 entities)105$1,172,241
Novartis12$915,290
Vertex3$809,207
Janssen Research & Development, LLC81$713,373
F. Hoffmann-la Roche AG47$669,971
Biocryst Pharmaceuticals, Inc.39$667,348
Boehringer Ingelheim International GmbH141$639,273
AstraZeneca(2 entities)14$618,864
Sunovion Pharmaceuticals Inc.499$614,548
Gilead60$513,123
Astellas Pharma Inc66$506,551
Roche TCRC, Inc.13$488,782
Axsome Therapeutics, Inc.15$487,525
Deciphera Pharmaceuticals Inc.30$438,208
United Therapeutics Corporation10$436,244
Blueprint Medicines Corporation48$428,382
GSK57$404,801
Immedica Pharma US, Inc.7$372,404
Rockwell Medical, Inc.27$368,102
Insmed, Inc.25$360,771
Springworks Therapeutics, Inc.4$351,813
PTC Therapeutics, Inc.22$323,821
UCB SA2$318,810
Lexicon Pharmaceuticals, Inc.26$317,436
Braintree Laboratories, Inc.21$297,093
X4 Pharmaceuticals, Inc.85$258,404
Otsuka Pharmaceutical Development & Commercialization, Inc.1$249,592
Astrazeneca AB2$241,149
EMD Serono, Inc.10$217,667
Neurocrine Biosciences, Inc.28$211,735
Taiho Oncology, Inc.13$197,477
Bausch Health US, LLC13$194,592
Novo Nordisk AS60$162,093
Principia Biopharma Inc.16$153,096
Grifols, S.A.15$148,967
G1 Therapeutics, Inc.17$129,885
Ipsen Bioscience Inc.15$129,612
Agios Pharmaceuticals, Inc.8$125,146
Esperion Therapeutics, Inc.15$107,465
Rhythm Pharmaceuticals, Inc.3$74,655
Sage Therapeutics, LLC1$66,295
Exelixis Inc.6$65,805
Sobi, Inc21$65,405
Upsher-smith Laboratories LLC12$54,013
UCB, Inc.1$53,265
Zogenix Inc.17$34,897
Corcept Therapeutics6$33,140
Ipsen Pharma SAS2$21,294
Sumitomo Pharma America, Inc.7$17,948

How this compares

$41,141,476 in reported general payments places this provider in the 95th percentile of 756 nephrology providers in Florida.

See all nephrology providers in Florida →

Other nephrology in Orlando

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →